DE69126183D1 - LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente - Google Patents

LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente

Info

Publication number
DE69126183D1
DE69126183D1 DE69126183T DE69126183T DE69126183D1 DE 69126183 D1 DE69126183 D1 DE 69126183D1 DE 69126183 T DE69126183 T DE 69126183T DE 69126183 T DE69126183 T DE 69126183T DE 69126183 D1 DE69126183 D1 DE 69126183D1
Authority
DE
Germany
Prior art keywords
lps
medicines
novel
methodphosphorus
sds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69126183T
Other languages
English (en)
Inventor
Gen-Ichiro Soma
Kiyoshi Yoshimura
Daisuke Tsukioka
Den Ichi Mizuno
Haruyuki Tategaoka-Danc Oshima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2218599A external-priority patent/JPH0499481A/ja
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69126183D1 publication Critical patent/DE69126183D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/425Serratia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
DE69126183T 1990-08-20 1991-08-20 LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente Expired - Lifetime DE69126183D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2218599A JPH0499481A (ja) 1990-08-20 1990-08-20 新規細菌、新規lps、新規免疫機能活性化剤、新規動物用免疫機能活性化剤
JP31293290 1990-11-20

Publications (1)

Publication Number Publication Date
DE69126183D1 true DE69126183D1 (de) 1997-06-26

Family

ID=26522650

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69126183T Expired - Lifetime DE69126183D1 (de) 1990-08-20 1991-08-20 LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente

Country Status (5)

Country Link
US (2) US5346891A (de)
EP (2) EP0472467A3 (de)
AT (1) ATE153374T1 (de)
CA (2) CA2049533A1 (de)
DE (1) DE69126183D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346891A (en) * 1990-08-20 1994-09-13 Gen-Ichiro Soma Lipopolysaccharide-producing bacteria, lipopolysaccharides, and lipopolysaccharide-containing, medicines and veterinary medicines
EP0533517A1 (de) * 1991-08-20 1993-03-24 Chiba Flour Milling Co. Ltd. LPS enthaltenes Anti-Entzugsmittel
US6444654B1 (en) 1997-01-21 2002-09-03 Board Of Regents Of University Of Nebraska Isolated asgal lipopolysaccharides and use of same to inhibit innate immune response
US6172220B1 (en) * 1997-01-21 2001-01-09 Board Of Regents Of University Of Nebraska Isolated algal lipopolysaccharides and use of same to inhibit endotoxin-initiated sepsis
WO2000057719A1 (fr) * 1999-03-26 2000-10-05 Taiho Pharmaceutical Company, Ltd. Additifs pour aliments de crustacees ou de poissons et aliments
BR0009629A (pt) * 2000-12-08 2002-08-20 Embrapa - Empresa Brasileira De Pesquisa Agropecua Biocontrole de doenças de plantas causadas por espécies de fusarium com novos isolados de bacillus megaterium e pantoea agglomerans
PL397023A1 (pl) 2002-08-27 2012-03-26 Hiroshi Terada Środek leczniczy do leczenia AIDS
DK1449535T3 (da) 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
NZ586941A (en) * 2003-09-26 2012-05-25 Gen Ichiro Soma Fermentation with Pantoea agglomerans
EA018687B1 (ru) 2005-11-28 2013-09-30 Байомедикал Рисерч Груп Инк. Фракция гликолипидов ферментированных экстрактов биологического пищевого материала и фармацевтическая композиция, содержащая указанную фракцию
JP5440837B2 (ja) * 2009-03-26 2014-03-12 Tdk株式会社 信号伝達装置
US8753643B1 (en) * 2012-04-11 2014-06-17 Life-Science Innovations, Llc Spray dried compositions and methods of use

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US5023320A (en) * 1982-03-23 1991-06-11 Sloan-Kettering Institute For Cancer Research Process for the purification of physiologically active substance having antitumor activity
US5057598A (en) * 1983-05-06 1991-10-15 Centocor, Inc. Monoclonal antibodies reactive with endotoxin core
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US4755381A (en) * 1986-03-27 1988-07-05 Swiss Serum And Vaccine Institute Berne Klebsiella capsular polysaccharide vaccine
US4877611A (en) * 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US4842862A (en) * 1986-07-03 1989-06-27 International Minerals & Chemical Corp. Immunostimulating agents
US4980160A (en) * 1986-10-16 1990-12-25 Biogen, Inc. Combinations of tumor necrosis factors and anti-inflammatory agents and methods for treating malignant and non-malignant diseases
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
US4870158A (en) * 1987-01-05 1989-09-26 University Of Pittsburgh Of The Commonwealth System Of Higher Education Polymyxin lipopolysaccharide antigen and associated method
DE3850800T2 (de) * 1987-04-13 1994-11-17 Hitachi Ltd Supraleitendes Material und Verfahren zu dessen Herstellung.
US5023820A (en) * 1989-05-10 1991-06-11 Beloit Corporation System for monitoring roll density
JPH0449242A (ja) * 1990-06-15 1992-02-18 Chiba Seifun Kk 抗ヘルペス剤、動物用抗ヘルペス剤
JPH0449244A (ja) * 1990-06-15 1992-02-18 Chiba Seifun Kk 抗糖尿病剤、動物用抗糖尿病剤
JPH0449243A (ja) * 1990-06-15 1992-02-18 Chiba Seifun Kk コレステロール低下剤、動物用コレステロール低下剤
US5346891A (en) * 1990-08-20 1994-09-13 Gen-Ichiro Soma Lipopolysaccharide-producing bacteria, lipopolysaccharides, and lipopolysaccharide-containing, medicines and veterinary medicines
US5281583A (en) * 1990-08-20 1994-01-25 Den'ichi Mizuno LPS-containing analgesics and veterinary analgesics
EP0533517A1 (de) * 1991-08-20 1993-03-24 Chiba Flour Milling Co. Ltd. LPS enthaltenes Anti-Entzugsmittel

Also Published As

Publication number Publication date
EP0477050A3 (en) 1993-03-17
US5346891A (en) 1994-09-13
CA2049548C (en) 2002-07-02
US5494819A (en) 1996-02-27
ATE153374T1 (de) 1997-06-15
EP0477050B1 (de) 1997-05-21
EP0472467A2 (de) 1992-02-26
EP0477050A2 (de) 1992-03-25
CA2049533A1 (en) 1992-02-21
CA2049548A1 (en) 1992-02-21
EP0472467A3 (en) 1993-03-17

Similar Documents

Publication Publication Date Title
FR2680512B1 (fr) Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
AR018042A1 (es) Uso de compuestos de quinolina para la preparacion de medicamentos para el tratamiento de infecciones bacterianas en mamiferos, particularmenteen el hombre, composiciones farmaceuticas formuladas con dichos compuestos y procedimiento de preparacion de dichos compuestos de quinolina
BG103292A (en) 6-0-substituted ketolides possessing antibacterial effect
GEP19991538B (en) Derivatives of Erytromycin and Pharmaceutical Composition on their Basis
SE8201311L (sv) Nya erytromycinforeningar, forfarande for framstellning av dessa och deras anvendning vid bekempning av bakterier
ATE169317T1 (de) Pyridobismidazole enthaltendes rigid-rod-polymer
DE69126183D1 (de) LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente
PL325339A1 (en) Derivatives of piperasine as neurokinin antagonists
FR2684385B1 (fr) Heparosanes-n,o-sulfates de haute masse moleculaire, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FI892454A0 (fi) Nya bensimidazolderivat, foerfarande foer framstaellning av desamma och farmaceutisk komposition innehaollande desamma.
ES2193246T3 (es) Cefalosporinas antibacterianas.
DE68910420D1 (de) Benzotriazolgruppenhaltiges Diorganopolysiloxan.
NO971625L (no) Nye peptider med immunomodulatoriske effekter
FR2656609B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
FI973221A (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
PT866791E (pt) Diaminopirimidinas formulacoes farmaceuticas que as contem e sua utilizacao antibacteriana
DE68908096D1 (de) Derivat des o-antigens von streptolysin, seine herstellung und verwendungen.
MX9708611A (es) Compuestos de dialquiltiacumicina.
ATE128714T1 (de) Erythromycinderivate.
GEP20002271B (en) Bicyclic Tachykinins Antagonists, Pharmaceutical Composition on Its Basis and Their Use
FR2651230B1 (fr) Derives de la 5-amino-1,2,3,4 tetrahydro-acridine et applications comme medicaments.
NO174963C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 8-fluorantracyklinglucosider
FR2673944B1 (fr) Derives de l'1,8-naphtalimide, leur procede de preparation et les compositions pharmaceutiques les contenant.
DE69116057D1 (de) Mikrobische Herstellung des 13-beta-13-deoxy-22,23,-dihydroavermectin-Bla/B1b-Aglycons
FR2654429B1 (fr) Nouveaux derives du methyl-2-propionate de 3,3,5-trimethylcyclohexanol, leur procede de preparation ainsi que compositions therapeutiques les contenant.

Legal Events

Date Code Title Description
8332 No legal effect for de